SEC Comment Letter for Axogen, Inc. (AXGN) (CIK 0000805928) (AXGN) — Jun 16, 2020
Axogen, Inc. (AXGN) (CIK 0000805928)
Date: June 16, 2020 · CIK: 0000805928 · Accession: 0000000000-20-005356
AI Filing Summary & Sentiment
File numbers found in text: 001-36046
Letter
United States securities and exchange commission logo June 16, 2020 Peter Mariani Chief Financial Officer Axogen, Inc. 13631 Progress Boulevard, Suite 400 Alachua, FL 32615 Re:Axogen, Inc. Form 10-K for the Fiscal Year Ended December 31, 2019 Filed February 24, 2020 File No. 001-36046 Dear Mr. Mariani: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 16, 2020
Peter Mariani
Chief Financial Officer
Axogen, Inc.
13631 Progress Boulevard, Suite 400
Alachua, FL 32615
Re:Axogen, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2019
Filed February 24, 2020
File No. 001-36046
Dear Mr. Mariani:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences